393 First-in-human phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: initial phase 1 results oleh Vivek Khemka, Claire Friedman, Georgia Kollia, Paolo Ascierto, Mark O’Hara, Lee James, Bruce Fischer, Shilpa Demes, Martin Kozicki, Palanikumar Ravindran, Jacqueline Shoukry, Mona Yunan, Ashish Massey